Lv11
38 积分 2024-10-24 加入
CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation
1小时前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
5天前
已完结
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials
5天前
已完结
Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis
6天前
已完结
JAK-STAT pathway targeting for the treatment of inflammatory bowel disease
12天前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
12天前
已完结
Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases
13天前
已完结
Neutrophils: from IBD to the gut microbiota
19天前
已完结
Group 3 innate lymphoid cells in intestinal health and disease
19天前
已完结
Interleukin-10-deficient mice develop chronic enterocolitis
19天前
已完结
皖公网安备34019202002308
